Laddar...
Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model
Combination therapy may enhance imipenem/cilastatin/relebactam’s (I/R) activity against Pseudomonas aeruginosa and suppress resistance development. Human-simulated unbound plasma concentrations of I/R at 1.25 g every 6 h (h), colistin at 360 mg daily, and amikacin at 25 mg/kg daily were reproduced a...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Microbiology
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7674065/ https://ncbi.nlm.nih.gov/pubmed/33139283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01764-20 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|